NE-58095
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NE-58095, covering 2017-02-23 to 2017-02-23. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 Tablets [Phase 2, Phase 3]